
zzso is critical to the growth of human tumors and the development of zzso zzso the many zzso mechanisms identified, the vascular zzso growth factor zzso signaling zzso has been implicated as the key regulator of tumor zzso Various therapeutic agents targeting the zzso zzso have been successfully developed, with many now approved and in routine clinical zzso In general, zzso zzso can be inhibited by 2 zzso zzso directed against zzso zzso or zzso receptors zzso and zzso zzso zzso targeting the zzso Thus far, clinical benefits achieved with zzso agents are limited by their modest efficacy and the development of zzso With no shortage of drugs in development, the lack of zzso zzso to predict for response or resistance to zzso therapies is now becoming a key factor limiting the further rational development of this class of zzso zzso This review discusses the biology of zzso zzso the clinical efficacy of zzso therapies, potential mechanisms of resistance, and emerging zzso zzso 

